F.M.F. Vergara et al. / European Journal of Medicinal Chemistry 44 (2009) 4954–4959
4959
4.2. General procedures for biological tests
References
[4] A. Adams, N. de Kimpe, Food Chem. 101 (2007) 1230.
[5] Y. Wang, J.B. Gloer, J.A. Scott, D. Malloch, J. Nat. Prod. 58 (1995) 93.
[6] R.J. Stonard, S. Ayer, J.J. Kotyk, L.J. Letendre, C.I. McGary, T.E. Nickson, N. Le-Van,
P. Lavrik, in: P.A. Hedin, J.J. Menn, R.M. Hollingworth (Eds.), Natural and
Engineered Pest Management Agents, American Chemical Society, 1994, pp.
25–36 Chapter 3.
4.2.1. Cell viability assay
The cellular viability for a macrophage cell line J774 (ATCC
TIB-67Ô) was determined by Mosmans’s MTT (3-(4,5-dimethylth-
ylthiazol-2yl)-2,5-dimethyl tetrazolium bromide; Merck) micro-
cultured tetrazolium assay. We evaluated non infected or infected
macrophages with M. bovis Bacillus Calmette–Guerin (BCG) in the
presence and absence of test compounds (4–29). The cells were
[7] M. Dolezal, Chem. Listy 100 (2006) 959.
plated in flat bottom 96 well plates (2.5 ꢂ106 cells/well/100
mL)
[8] M.V.N. De Souza, Rec. Pat. Anti-Infect. Drug Discov. 1 (2006) 33.
[9] M.V.N. De Souza, Curr. Opin. Pulm. Med. 12 (2006) 167.
[10] A. Somoskovi, L.M. Parsons, M. Salfinger, Respir. Res. 2 (2001) 164.
[11] A.C. Pinheiro, C.R. Kaiser, M.C.S. Lourenco, M.V.N. De Souza, J.L. Wardell,
S.M.S.V. Wardell, J. Chem. Res. 3 (2007) 180.
cultured for 24 h in a controlled atmosphere (CO2 5% at 37 ꢁC), and
non-adherent cells were washed by gentle flushing with RPMI 1640
supplemented with fetal bovine serum (10%) and gentamicin
(25
m
g/mL). Adherent cells were infected or not with BCG (2.5 ꢂ106
[12] Y. Zhang, M.M. Wade, A. Scorpio, J. Antimicrob. Chemother. 52 (2003) 790.
´
[13] P. Jureen, J. Werngren, J.C. Toro, S. Hoffner, Antimicrob. Agents Chemother. 52
UFC/well/100 mL) cultured in the presence of medium alone, tween
(5) (2008) 1852.
[14] S. Rollas, S.G. Ku¨ çu¨kgu¨ zel, Mol. 12 (2007) 1910.
[15] S.A. Carvalho, E.F. Da Silva, M.V.N. De Souza, M.C.S. Lourenço, F.R.C. Vicente,
Bioorg. Med. Chem. Lett. 18 (2008) 538.
[16] M.L. Ferreira, L.N.F. Cardoso, R.S.B. Gonçalves, E.T. Silva, M.C.S. Lourenço,
M.V.N. De Souza, Lett. Drug Des. Discov. 5 (2008) 137.
[17] M.C. Lourenco, M.L. Ferreira, M.V.N. De Souza, M.A. Peralta, T.A. Vasconcelos,
M.G.M.O. Henrique, Eur. J. Med. Chem. 43 (2008) 1344.
[18] M.C.S. Lourenco, M.V.N. Souza, A.C. Pinheiro, M.L. Ferreira, R.S.B. Gonçalves,
T.C.M. Nogueira, M.A. Peralta, Arkivoc. 15 (2007) 181.
[19] M.V.N. De Souza, T.A. Vasconcelos, S.C.P. Mello, S.M.S.V. Wardell, M.A. Peralta,
B. Ferreira, M.G.M.O. Henrique, I. Neves Junior, M.C.S. Lourenço, Lett. Drug Des.
Discov. 2 (2005) 563.
[20] R. Govindarajan, H.J. Jameela, A.R. Bhat, Indian J. Heterocycl. Chem. 12 (3)
(2003) 229.
20 (3%) (live and dead controls, respectively) or different concen-
trations of compounds (1.0, 10.0 and 100 g/mL) in a triplicate
assay. After 48 h, stock MTT solution (5 mg/mL of saline; 20 mL/
well) was added to the culture and 4 h later, the plate was centri-
fuged for 2 min at 2800 rpm, supernatant was discharged and
Dimethyl sulfoxide (DMSO) (100 mL/well) was added for formazan
crystals solubilization and the absorbance was read at 540 nm in
a plate reader (Biorad – 450).
m
4.2.2. Antimycobacterial activity
Briefly, 200 mL of sterile deionized water was added to all
outer-perimeter wells of sterile 96 well plates (falcon, 3072:
Becton Dickinson, Lincoln Park, NJ) to minimize evaporation of the
medium in the test wells during incubation. The 96 plates received
100 mL of the Middlebrook 7H9 broth (Difco laboratories, Detroit,
MI, USA) and a serial dilution of the compounds 4–29 was made
[21] X.F. Shi, C.C. Yuan, Acta. Crystallogr. E62 (11) (2006) 5232.
[22] N. Sinha, S. Jain, A. Tilekar, R.S. Upadhayaya, N. Kishore, R.K. Sinha, S.K. Arora,
Arkivoc. 2 (2005) 9.
[23] T.S. Gardner, F.A. Smith, E. Wenis, J. Lee, J. Org. Chem. 21 (5) (1956) 530.
[24] X.F. Shi, C.C. Yuan, Acta. Crystallogr. E62 (8) (2006) 3290.
[25] X.F. Shi, Z.Y. Xing, Acta. Crystallogr. E63 (12) (2007) 4723.
[26] M.C. Souza., A.C. Siani, M.F.S. Ramos, M.G.M.O. Henrique, Pharm. 58 (2003) 582.
[27] M.V. Carvalho, C.P. Monteiro, A.C. Siani, L.M.M. Valente, M.G.M.O. Henrique,
Inflammopharmacology 14 (2006) 48.
[28] J. Canetti, E. Rist, R. Grosset, Rev. Tuberc. Pneumol. 27 (1963) 212.
[29] S.G. Franzblau, R.S. Witzig, J.C. McLaughlin, P. Torres, G. Madico, A. Hernandez,
M.T. Degnan, M.B. Cook, V.K. Quenzer, R.M. Ferguson, R.H. Gilman, J. Clin.
Microbiol. 36 (1998) 362.
[30] R.S. Reis, I. Neves Jr., S.L.S. Lourenço, L.S. Fonseca, M.C.S. Lourenço, J. Clin.
Microbiol. 42 (2004) 2247.
directly on the plate. The final drug concentrations tests were
0.01–100
m
g/mL. Plates were covered and sealed with parafilm
L of
and incubated at 37 ꢁC for five days. After this time, 25
m
a freshly prepared 1:1 mixture of Alamar Blue (Accumed Inter-
national, Westlake, Ohio) reagent and 10% tween 80 was added to
plate and incubated for 24 h. A blue color in the well was inter-
preted as no bacterial growth, and a pink color was scored as
growth. The MIC (minimal inhibition concentration) was defined
as the lowest drug concentration, which prevented a color change
from blue to pink.
[31] J.D. Vanitha, C.N. Paramasivan, Diagn. microbiol. infect. dis. 49 (2004) 179.
[32] S.A. Hall, P.E. Spoerri, J. Am. Chem. Soc. 62 (3) (1940) 664.
[33] S.M.S. Wardell, M.V.N. De Souza, J.L. Wardell, J.N. Lowc, C. Glidewell, Acta.
Crystallogr. E62 (2006) 3765.